Trial Profile

A Phase II Single-Arm Study of Atezolizumab Monotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Clinical Evaluation of Novel Blood-Based Diagnostics

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 01 Jun 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Atezolizumab (Primary)
Indications Non-small cell lung cancer
Focus Biomarker; Therapeutic Use
Acronyms B-F1RST
Sponsors Genentech

Most Recent Events

01 May 2022 Results published in the Nature Medicine
29 Jul 2019 Status changed from active, no longer recruiting to completed.
03 Apr 2019 Results of the exploratory subgroup analysis of atezolizumab clinical characteristics in patients with low circulating tumor DNA, presented at the 110th Annual Meeting of the American Association for Cancer Research

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com